COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells

Stanislovas S Jankauskas1, Urna Kansakar1, Celestino Sardu2

  • 1Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.

Insights

Serum from patients who did not survive COVID-19 significantly increased lipid peroxidation and ferroptosis markers in human endothelial cells, highlighting a link between disease severity and cellular damage.

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Pathophysiology

Background:

  • COVID-19 (coronavirus disease 2019) pathophysiology involves oxidative stress and endothelial dysfunction.
  • Lipid peroxidation and ferroptosis are critical cellular processes implicated in disease severity.

Purpose of the Study:

  • To investigate the impact of COVID-19 on lipid peroxidation and ferroptosis in human endothelial cells.
  • To determine if COVID-19-induced oxidative stress and lipid peroxidation correlate with patient outcomes.

Main Methods:

  • Human endothelial cells were incubated with serum from COVID-19 patients (survivors vs. non-survivors).
  • Assessed reactive oxygen species (ROS) generation and lipid peroxidation.
  • Analyzed expression levels of ferroptosis markers (GPX4, SLC7A11, FTH1, SAT1).
  • Investigated the role of TNFR1 by silencing it in endothelial cells.

Main Results:

  • Serum from non-survivors significantly increased lipid peroxidation in endothelial cells.
  • Non-survivor serum markedly altered expression of key ferroptosis markers.
  • TNFR1 silencing rescued the ferroptosis-related gene expression changes.

Conclusions:

  • Serum from non-surviving COVID-19 patients induces lipid peroxidation in human endothelial cells.
  • These findings suggest a mechanism linking COVID-19 severity to endothelial cell damage via lipid peroxidation and ferroptosis.